NeuralTrust Launches AI Agent Security Platform

NeuralTrust Launches AI Agent Runtime Security Gateway

As enterprises move from AI assistants toward autonomous AI agents capable of executing tasks, accessing data, and interacting with business systems, security teams face a new challenge: protecting dynamic AI behavior rather than individual applications. NeuralTrust has launched an AI agent runtime security platform designed to protect multiple AI agents through a single security gateway,…

Read More: NeuralTrust Launches AI Agent Runtime Security Gateway
Ambition Launches AI Skills for Sales Teams

Ambition Launches AI Agent Skills to Automate Sales Coaching Workflows

Sales performance platform Ambition has launched Agent Skills, a new AI workflow library designed to automate core revenue management processes including coaching preparation, pipeline reviews, forecasting analysis, and performance evaluations. The company says the new capability aims to help sales organizations scale consistent coaching practices while giving executives, managers, and sales representatives faster access to…

Read More: Ambition Launches AI Agent Skills to Automate Sales Coaching Workflows
CollectivIQ AI Consensus Platform Improves Accuracy

CollectivIQ AI Consensus Platform Claims Higher Accuracy Than Frontier Models

As enterprises increasingly rely on artificial intelligence for research, analysis, and strategic decisions, accuracy and trustworthiness have become major challenges. CollectivIQ, an AI consensus platform for business intelligence, has released benchmark results showing its multi-model reasoning architecture can outperform individual large language models (LLMs) by combining responses from multiple AI systems, including ChatGPT, Gemini, Claude,…

Read More: CollectivIQ AI Consensus Platform Claims Higher Accuracy Than Frontier Models
GenScript Connects AI Drug Design With Validation

GenScript and Tamarind Bio Connect AI Drug Design With Lab Validation

Artificial intelligence is accelerating the pace of molecular discovery, enabling researchers to generate thousands of potential drug candidates in the time traditional methods required to design only a handful. However, transforming AI-generated designs into viable therapies still depends on experimental validation. GenScript Biotech Corporation and Tamarind Bio are addressing this challenge through a strategic partnership…

Read More: GenScript and Tamarind Bio Connect AI Drug Design With Lab Validation
Olio Labs Uses AI to Predict Drug Trial Outcomes

Olio Labs Uses AI Vision Models to Predict Drug Safety Outcomes Before Trials

Artificial intelligence is increasingly being used to address one of drug development’s biggest challenges: predicting whether promising therapies will succeed in humans. Olio Labs has announced research showing that its AI-powered preclinical platform can forecast potential clinical outcomes, including gastrointestinal side effects, cardiac toxicity, neuropsychiatric effects, and long-term weight changes, using advanced behavioral analysis of…

Read More: Olio Labs Uses AI Vision Models to Predict Drug Safety Outcomes Before Trials
Cephia Names Mike McAuliffe as AI Sensor CEO

Cephia Names Semiconductor Veteran Mike McAuliffe CEO to Scale AI Vision Platform

AI-native imaging company Cephia has appointed semiconductor and computer vision executive Mike McAuliffe as President and Chief Executive Officer, signaling a new phase of commercialization for its next-generation image sensor technology. The leadership move comes as demand grows for compact AI perception systems powering physical AI applications across robotics, automotive, drones, healthcare, satellites, and industrial…

Read More: Cephia Names Semiconductor Veteran Mike McAuliffe CEO to Scale AI Vision Platform
AI Reshapes Business Risk and Investment Strategy

Egan-Jones Report Examines How AI Is Reshaping Business and Investment Risk

Artificial intelligence and autonomous technologies are moving from experimental concepts into real-world systems that could reshape competitive markets, according to a new analysis from Egan-Jones Ratings Company. The report examines how advances in AI, automation, and autonomous decision-making are challenging traditional business models while creating new considerations for institutional investors, credit analysts, and enterprise risk…

Read More: Egan-Jones Report Examines How AI Is Reshaping Business and Investment Risk
AI Search Is Reshaping Brand Consistency

AI Search Is Redefining Brand Consistency as Answer Engines Replace Traditional Discovery

The rise of generative AI search is transforming how brands are discovered online. Instead of directing users to a list of websites, AI-powered answer engines increasingly synthesize information into direct responses, making brand consistency a strategic requirement rather than simply a marketing best practice. According to creative studio della, organizations must now ensure that every…

Read More: AI Search Is Redefining Brand Consistency as Answer Engines Replace Traditional Discovery
Insilico Advances AI-Designed Eye Disease Drug

Insilico Medicine Advances AI-Designed Eye Disease Drug Candidate Into Preclinical Development

Generative AI is continuing to reshape drug discovery as biotechnology companies use machine learning to shorten development timelines and identify novel therapeutic targets. Insilico Medicine has announced the nomination of ISM9077 as its latest preclinical candidate, an AI-designed small-molecule therapy aimed at treating multiple inflammatory eye diseases while also supporting broader research into aging and…

Read More: Insilico Medicine Advances AI-Designed Eye Disease Drug Candidate Into Preclinical Development

Grow Your
Brand Visibility

Looking to publish a press release, guest article, interview or podcast? Connect with us.

GET FEATURED
Subscribe

Sign up today for exclusive insights and updates.

Newsletter Signup